These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 19406215

  • 1. Tyrosine hydroxylase-positive amacrine interneurons in the mouse retina are resistant against the application of various parkinsonian toxins.
    Nagel F, Bähr M, Dietz GP.
    Brain Res Bull; 2009 Jun 30; 79(5):303-9. PubMed ID: 19406215
    [Abstract] [Full Text] [Related]

  • 2. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T.
    Eur Neuropsychopharmacol; 2005 Jan 30; 15(1):57-67. PubMed ID: 15572274
    [Abstract] [Full Text] [Related]

  • 3. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
    Otto D, Unsicker K.
    J Neurosci Res; 1993 Mar 01; 34(4):382-93. PubMed ID: 8097265
    [Abstract] [Full Text] [Related]

  • 4. Tripchlorolide protects against MPTP-induced neurotoxicity in C57BL/6 mice.
    Hong Z, Wang G, Gu J, Pan J, Bai L, Zhang S, Chen SD.
    Eur J Neurosci; 2007 Sep 01; 26(6):1500-8. PubMed ID: 17714494
    [Abstract] [Full Text] [Related]

  • 5. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
    Mitsumoto Y, Watanabe A, Mori A, Koga N.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):660-3. PubMed ID: 9703982
    [Abstract] [Full Text] [Related]

  • 6. Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTP.
    Walters TL, Irwin I, Delfani K, Langston JW, Janson AM.
    Exp Neurol; 1999 Mar 30; 156(1):62-70. PubMed ID: 10192777
    [Abstract] [Full Text] [Related]

  • 7. Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model.
    Tapias V, Cannon JR, Greenamyre JT.
    J Neurosci Res; 2010 Feb 01; 88(2):420-7. PubMed ID: 19681169
    [Abstract] [Full Text] [Related]

  • 8. Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).
    Ito T, Suzuki K, Uchida K, Nakayama H.
    Exp Toxicol Pathol; 2013 Jan 01; 65(1-2):153-8. PubMed ID: 21855308
    [Abstract] [Full Text] [Related]

  • 9. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW, Nixon K, Hogg E, McNeill T, Petzinger GM.
    J Neurosci Res; 2004 May 15; 76(4):539-50. PubMed ID: 15114626
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX, Chen WF, Xie JX, Wong MS.
    Neurosci Res; 2008 Feb 15; 60(2):156-61. PubMed ID: 18054104
    [Abstract] [Full Text] [Related]

  • 11. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM, Chen X, Luo DZ, Zhang XH, Xue H, Zheng LF, Yang N, Wang XM, Zhu JX.
    Neuroscience; 2008 May 15; 153(3):634-44. PubMed ID: 18420351
    [Abstract] [Full Text] [Related]

  • 12. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
    Anderson DW, Bradbury KA, Schneider JS.
    Eur J Neurosci; 2008 Aug 15; 28(3):610-7. PubMed ID: 18702732
    [Abstract] [Full Text] [Related]

  • 13. Neuroprotection in Parkinson models varies with toxin administration protocol.
    Anderson DW, Bradbury KA, Schneider JS.
    Eur J Neurosci; 2006 Dec 15; 24(11):3174-82. PubMed ID: 17156378
    [Abstract] [Full Text] [Related]

  • 14. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Inden M, Kitamura Y, Tamaki A, Yanagida T, Shibaike T, Yamamoto A, Takata K, Yasui H, Taira T, Ariga H, Taniguchi T.
    Neurochem Int; 2009 Dec 15; 55(8):760-7. PubMed ID: 19647776
    [Abstract] [Full Text] [Related]

  • 15. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/bl and CD-1 mice.
    Muthane U, Ramsay KA, Jiang H, Jackson-Lewis V, Donaldson D, Fernando S, Ferreira M, Przedborski S.
    Exp Neurol; 1994 Apr 15; 126(2):195-204. PubMed ID: 7925820
    [Abstract] [Full Text] [Related]

  • 16. Estrogen interacts with the IGF-1 system to protect nigrostriatal dopamine and maintain motoric behavior after 6-hydroxdopamine lesions.
    Quesada A, Micevych PE.
    J Neurosci Res; 2004 Jan 01; 75(1):107-16. PubMed ID: 14689453
    [Abstract] [Full Text] [Related]

  • 17. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
    Liu J, Wang YY, Liu L, Wang QD, Yuan ZY, Zhang ZX, Gu P, Wang MW.
    Neurosci Lett; 2008 Dec 26; 448(2):184-8. PubMed ID: 18977411
    [Abstract] [Full Text] [Related]

  • 18. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM, Banerjee R, Senthilkumar KS, Saravanan KS, Raju BC, Rao JM, Mohanakumar KP.
    Pharmacol Biochem Behav; 2006 Jun 26; 84(2):321-9. PubMed ID: 16820197
    [Abstract] [Full Text] [Related]

  • 19. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK, Choi BH, Huang X, Snyder BJ, Bukhari S, Kong TH, Park H, Park HC, Park SR, Ha Y.
    Eur J Neurosci; 2009 Mar 26; 29(5):891-900. PubMed ID: 19245369
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
    Alvarez-Fischer D, Henze C, Strenzke C, Westrich J, Ferger B, Höglinger GU, Oertel WH, Hartmann A.
    Exp Neurol; 2008 Mar 26; 210(1):182-93. PubMed ID: 18053987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.